figshare
Browse
12885_2021_8725_MOESM3_ESM.docx (36.58 kB)

Additional file 3 of How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

Download (36.58 kB)
journal contribution
posted on 2021-09-02, 03:31 authored by Mikyung Kelly Seo, John Cairns
Additional file 3. PRISMA flow diagram of study selection.

History

Usage metrics

    BMC Cancer

    Categories

    Keywords

    BiomarkerCompanion biomarkerCompanion diagnosticPrecision medicineTargeted therapyOncologyCancerEconomic evaluationHealth economicsCost-effectivenessSystematic review

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC